conopressin g has been researched along with 1-methyl-3-isobutylxanthine in 1 studies
Studies (conopressin g) | Trials (conopressin g) | Recent Studies (post-2010) (conopressin g) | Studies (1-methyl-3-isobutylxanthine) | Trials (1-methyl-3-isobutylxanthine) | Recent Studies (post-2010) (1-methyl-3-isobutylxanthine) |
---|---|---|---|---|---|
18 | 0 | 2 | 5,148 | 5 | 279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kits, KS; Lodder, JC; Van Soest, PF | 1 |
1 other study(ies) available for conopressin g and 1-methyl-3-isobutylxanthine
Article | Year |
---|---|
Activation of protein kinase C by oxytocin-related conopressin underlies pacemaker current in Lymnaea central neurons.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Biological Clocks; Bucladesine; Calcium; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Lymnaea; Neurons; Oxytocin; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Phosphorylation; Protein Kinase C; Signal Transduction; Staurosporine | 2000 |